{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:09:25Z","timestamp":1793286565791,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1053\/j.jvca.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:55:53Z","timestamp":1752602153000},"page":"2626-2635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of Two Activated Clotting Time Targets During Cardiac Surgery With Cardiopulmonary Bypass: A Prospective Multicenter Randomized Controlled Trial"],"prefix":"10.1053","volume":"39","author":[{"given":"Karin A.M.","family":"Gorter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco C.","family":"Stehouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"de Vroege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannique","family":"Zuthof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Meesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed D.","family":"Niesten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.L.","family":"Suyker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2025.07.001_bib0001","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.athoracsur.2006.06.072","article-title":"Thrombin during cardiopulmonary bypass","volume":"82","author":"Edmunds","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0002","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0003-4975(01)03211-8","article-title":"Mechanisms and attenuation of hemostatic activation during extracorporeal circulation","volume":"72","author":"Despotis","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0003","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11239-008-0280-4","article-title":"Anticoagulant therapy during cardiopulmonary bypass","volume":"26","author":"Yavari","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2025.07.001_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/026765919801300603","article-title":"Platelets and cardiopulmonary bypass","volume":"13","author":"Hyde","year":"1998","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2025.07.001_bib0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1213\/00000539-199810000-00008","article-title":"Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass","volume":"87","author":"Mochizuki","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00000539-200107000-00005","article-title":"The effects of heparin, protamine, and heparin\/protamine reversal on platelet function under conditions of arterial shear stress","volume":"93","author":"Griffin","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0007","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.athoracsur.2005.12.027","article-title":"Protamine enhances fibrinolysis by decreasing cloth strength: Role of tissue factor-initiated thrombin generation","volume":"81","author":"Nielsen","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0008","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1537-2995.2004.04144.x","article-title":"The independent association of massive blood loss with mortality in cardiac surgery","volume":"44","author":"Karkouti","year":"2004","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2025.07.001_bib0009","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1051\/ject\/201345235","article-title":"Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgery","volume":"45","author":"Cuenca","year":"2013","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2025.07.001_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.jvca.2017.06.026","article-title":"2017 EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery","volume":"32","author":"Boer","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.07.001_bib0011","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-5223(19)41500-6","article-title":"Heparin therapy during extracorporeal circulation: II","volume":"69","author":"Bull","year":"1975","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0003-4975(10)63676-4","article-title":"Adequate anticoagulation during cardiopulmonary bypass determine by activated clotting time and the appearance of fibrin monomer","volume":"26","author":"Young","year":"1978","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0003-4975(94)92213-6","article-title":"Risk and benefit of low systemic heparinization during open heart operations","volume":"58","author":"Von Segesser","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0014","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0003-4975(97)01347-7","article-title":"Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits","volume":"65","author":"Aldea","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0015","article-title":"Comparison of blood concentration and weight-based heparin and protamine dosing strategies for cardiopulmonary bypass: A systematic review and meta-analysis","volume":"16","author":"Raner","year":"2024","journal-title":"Cureus"},{"key":"10.1053\/j.jvca.2025.07.001_bib0016","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1053\/j.jvca.2019.12.050","article-title":"Heparin dose and point-of-care measurements of hemostasis in cardiac surgery-Results of a randomized controlled trial","volume":"34","author":"Lax","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.07.001_bib0017","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1067\/mtc.2002.122551","article-title":"Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface","volume":"124","author":"Johnell","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0018","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/jcan.2002.124140","article-title":"The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits","volume":"16","author":"Ranucci","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.07.001_bib0019","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5761\/atcs.oa.21-00222","article-title":"A blinded randomized trial comparing standard activated clotting time heparin management to high target active clotting time and individualized Hepcon HMS heparin management in cardiopulmonary bypass cardiac surgical patients","volume":"28","author":"Nuttall","year":"2022","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0020","first-page":"2594","article-title":"Reporting of noninferiority and equivalence randomized trials","volume":"308","author":"Piaggio","year":"2012","journal-title":"Extension of the CONSORT 2010 statement"},{"key":"10.1053\/j.jvca.2025.07.001_bib0021","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa1413579","article-title":"A multicenter trial of remote ischemic preconditioning for heart surgery","volume":"373","author":"Meybohm","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.07.001_bib0022","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4097\/kja.23278","article-title":"Intention to treat versus as treated versus per protocol approaches to analysis","volume":"76","author":"Ahn","year":"2023","journal-title":"Korean J Anesthesiol"},{"key":"10.1053\/j.jvca.2025.07.001_bib0023","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0267659119867005","article-title":"Cardiopulmonary bypass and dual antiplatelet therapy: A strategy to minimise transfusions and blood loss","volume":"35","author":"Karlsson","year":"2020","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2025.07.001_bib0024","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0003-4975(96)00249-4","article-title":"Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study","volume":"62","author":"Aldea","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0003-4975(95)00366-S","article-title":"Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects","volume":"60","author":"Ovrum","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0026","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0003-4975(96)01099-5","article-title":"Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation","volume":"63","author":"Kuitunen","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0027","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1010-7940(96)80265-X","article-title":"Heparin-coated circuit in coronary surgery. A clinical study","volume":"10","author":"S\u00e1enz","year":"1996","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2025.07.001_bib0028","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0267659120924917","article-title":"Will high-dose heparin affect blood loss and inflammatory response in patients undergoing cardiopulmonary bypass?","volume":"36","author":"Braatz","year":"2021","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2025.07.001_bib0029","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0267659120949351","article-title":"A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass","volume":"36","author":"Li","year":"2021","journal-title":"Perfusion"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025005580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025005580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:12:31Z","timestamp":1762355551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077025005580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1053077025005580"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2025.07.001","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Two Activated Clotting Time Targets During Cardiac Surgery With Cardiopulmonary Bypass: A Prospective Multicenter Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}